Preprint Article Version 1 This version is not peer-reviewed

The Specific Legislation Governing Secondary Research on Biological Samples Invalidates the Accusations of Ethical Fraud Levelled against the IHU-MI

Version 1 : Received: 23 July 2024 / Approved: 23 July 2024 / Online: 23 July 2024 (18:05:07 CEST)

How to cite: Baudoux, V.; Nicolay, B.; Zizi, M. The Specific Legislation Governing Secondary Research on Biological Samples Invalidates the Accusations of Ethical Fraud Levelled against the IHU-MI. Preprints 2024, 2024071858. https://doi.org/10.20944/preprints202407.1858.v1 Baudoux, V.; Nicolay, B.; Zizi, M. The Specific Legislation Governing Secondary Research on Biological Samples Invalidates the Accusations of Ethical Fraud Levelled against the IHU-MI. Preprints 2024, 2024071858. https://doi.org/10.20944/preprints202407.1858.v1

Abstract

Background Compliance with research ethics legislation is crucial for protecting people's rights in clinical trials. Researchers can alert publishers when they have concerns about possible non-compliance with this legislation by other authors, and this opportunity for independent scrutiny is important. Nevertheless, some alerts may turn out to be unfounded due to a misunderstanding of the legislation. Methods We present the analysis of the article by F. Franck et al., « Raising concerns on questionable ethics approvals - a case study of 456 trials from the Institut Hospitalo-Universitaire Méditerranée Infection», in which the authors explain having sent numerous emails to different publishers to express their concerns about potential ethical breaches in publications from a single French institution. We analyzed in detail the 248 studies that the authors present as suspects. We have also studied the texts of French law. Results Our detailed analysis of these 248 studies discovered that only 8 of them report research involving humans. All the others are secondary research on existing biological samples. In France, as in many other countries, secondary research on biological samples does not involve human subjects. Conclusions Assessing the ethical conformity of scientific publications must be based on a precise knowledge of the legislation and a rigorous analysis of these publications. When researchers who alert publishers confuse research involving the human person with research not involving the human person, the publishers are in danger of being misled by these unfounded alerts. This can have deleterious consequences.

Keywords

Ethics; microbiology; non-RIPH studies; studies « hors loi Jardé »; biological samples; IRB exemption.

Subject

Medicine and Pharmacology, Other

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.